At Intarcia Therapeutics, Inc., employees are the keys to our purpose and success. We unleash our teamÍs talent, to unlock lifeÍs possibilities for patients with disruptively innovative medicines. Intarcia is a rapidly growing biopharmaceutical company developing innovative therapies that merge medicine and technology. We seek to transform the standard of care and improve patient outcomes in major therapeutic categories for serious chronic diseases, such as diabetes. We successfully completed our Phase 3 clinical trial program and submitted our New Drug Application filing for ITCA 650 in the U.S. in 2016. We are also developing a pipeline of products for our proprietary Medici Drug Delivery System» comprised of three unique technologies: 1) A stabilization technology that allows for proteins, peptides, antibody fragments, and other highly potent small molecules to be stabilized at or above human body temperatures for up to three years or more; 2) A matchstick-sized osmotic mini-pump that is placed just under the dermal layer of skin to deliver a continuous and consistent flow of medication; and 3) A placement technology including proprietary tools designed to provide an optimal user experience Intarcia LinkedIn Community Guidelines Welcome and thank you for engaging with us. We kindly ask you to follow our community guidelines below. ´ We are in a regulated industry and may not be able to respond to all posts. ´ While we support an open forum, please be respectful. ´ Please avoid mentions of brand name products. ´ We will not provide medical advice; for questions, please consult with your healthcare provider. ´ We do not endorse and are not responsible for third party links/content. ´ Please respect all trademark and copyright rules. ´ By interacting here, you agree to comply with LinkedInÍs rules and policies. ´ Failure to follow our guidelines may result in deletion of comments.